| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/08916939908994064 |
| P698 | PubMed publication ID | 10739336 |
| P2093 | author name string | Kahaleh MB | |
| LeRoy EC | |||
| P2860 | cites work | SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor | Q22008583 |
| The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes | Q24339000 | ||
| The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis | Q28137622 | ||
| Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes | Q28609747 | ||
| Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis | Q32142196 | ||
| Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon. | Q33565513 | ||
| Large vessel occlusive disease associated with CREST syndrome and scleroderma | Q33565537 | ||
| Labial capillary microscopy in systemic sclerosis | Q33565660 | ||
| Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis | Q33578731 | ||
| Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium | Q33905997 | ||
| Skin capillary blood flow in scleroderma | Q34060008 | ||
| Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells | Q34229735 | ||
| Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells | Q34573717 | ||
| Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. | Q35315000 | ||
| Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines | Q35749970 | ||
| Vascular fluid mechanics, the arterial wall, and atherosclerosis | Q35822929 | ||
| Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. | Q36306770 | ||
| Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. | Q36388240 | ||
| Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke | Q36790035 | ||
| IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines | Q37351068 | ||
| Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma | Q37358399 | ||
| Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds | Q37382837 | ||
| Mechanisms of the protective effects of transforming growth factor-beta in reperfusion injury | Q37419534 | ||
| Regulatory functions of the vascular endothelium | Q37816182 | ||
| Cell biology of von Willebrand factor | Q38023527 | ||
| Image analysis quantification of peptide-immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosis | Q39248686 | ||
| Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis | Q39397697 | ||
| Antiendothelial cell antibodies: useful markers of systemic sclerosis | Q39448876 | ||
| The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis | Q39803893 | ||
| Pulmonary vascular changes in scleroderma | Q39854610 | ||
| Interactions between cytokines and nitric oxide | Q40381284 | ||
| Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone | Q40567511 | ||
| Pathogenesis of systemic sclerosis: A vascular hypothesis | Q41069217 | ||
| Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals | Q41111846 | ||
| Perturbation of fibrinolysis inhibitors in progressive systemic sclerosis | Q41280217 | ||
| The inflammatory response to cardiopulmonary bypass | Q41480038 | ||
| Fluid shear stress-mediated signal transduction: how do endothelial cells transduce mechanical force into biological responses? | Q41500501 | ||
| Proliferation and the monoclonal origins of atherosclerotic lesions | Q41724154 | ||
| Pulsatile and steady flow induces c-fos expression in human endothelial cells | Q42509401 | ||
| Is occupational organic solvent exposure a risk factor for scleroderma? | Q42541669 | ||
| Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. | Q42607833 | ||
| Inhibition of platelet-derived mitogen release by nitric oxide (EDRF). | Q42798216 | ||
| Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action | Q43433507 | ||
| Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine | Q48466824 | ||
| Treatment of Raynaud's phenomenon by fibrinolytic enhancement | Q48581900 | ||
| Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls | Q49051672 | ||
| Cytolytic activity against allogeneic human endothelia: resistance of cytomegalovirus-infected cells and virally activated lysis of uninfected cells. | Q54130379 | ||
| How do cytotoxic lymphocytes kill their targets? | Q57720900 | ||
| Nitric oxide inhibits stress-induced endothelial cell apoptosis | Q57773650 | ||
| Venodilation in Raynaud's disease | Q58817270 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 195-214 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Autoimmunity | Q4826348 |
| P1476 | title | Autoimmunity and vascular involvement in systemic sclerosis (SSc). | |
| P478 | volume | 31 |
| Q44363752 | Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9. |
| Q38648592 | An overview of environmental risk factors in systemic sclerosis |
| Q44062256 | Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway |
| Q73810384 | Association of humoral immunity and bronchiolitis obliterans syndrome |
| Q37780253 | At the heart of tissue: endothelin system and end-organ damage |
| Q21195262 | Cardiovascular disease in systemic sclerosis--an emerging association? |
| Q74024150 | Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression |
| Q34770486 | Coagulation and autoimmunity in scleroderma interstitial lung disease. |
| Q33668640 | Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H |
| Q36757042 | Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors |
| Q50683587 | Early identification of vascular damage in patients with systemic sclerosis. |
| Q42870658 | Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma |
| Q33826259 | Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin. |
| Q35078513 | IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway |
| Q35084903 | Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis |
| Q24802883 | MCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblasts |
| Q38516265 | Macro- and microvascular disease in systemic sclerosis |
| Q40134411 | Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis |
| Q52659036 | MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis. |
| Q36434142 | Microvascular damage in systemic sclerosis: detection and monitoring with biomarkers |
| Q46012346 | Organ involvement in Argentinian systemic sclerosis patients with "late" pattern as compared to patients with "early/active" pattern by nailfold capillaroscopy. |
| Q24811751 | Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice. |
| Q35100214 | Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitro |
| Q37515708 | Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin |
| Q33588440 | Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study |
| Q36132271 | Role of endothelin in fibrosis and anti-fibrotic potential of bosentan |
| Q38603115 | Skin autofluorescence, as marker of accumulation of advanced glycation endproducts and of cumulative metabolic stress, is not increased in patients with systemic sclerosis |
| Q44448110 | Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease |
| Q81510541 | Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis |
| Q64111768 | Study of MRI brain findings and carotid US features in systemic sclerosis patients, relationship with disease parameters |
| Q46531962 | Systemic sclerosis following oral contraception |
| Q46463194 | The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function |
| Q42203442 | The role of platelets in the pathogenesis of systemic sclerosis |
| Q38663003 | Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases. |
| Q37344793 | Vascular disease in scleroderma |
Search more.